Last October 29th the employers’ organization of the pharmaceutical industry in Spain, Farmaindustria, organized its latest Farma-Biotech meeting to boost pre-clinical research.
The event brings together representatives of national and international pharmaceutical companies with different Spanish biotechnology companies and research groups that have innovative clinical projects. Nanoligent and six other projects were hosted because according to Farmaindustra “they have reached an adequate level of maturity to study possible agreements with companies”. Farmaindustria has held this type of meetings since 2011 to promote biomedical research and accelerate the transfer of new medicines from small companies to medical practice.
